These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6135389)

  • 1. Beta receptor blocking agents in the secondary prevention of coronary heart disease.
    Vedin JA; Wilhelmsson CE
    Annu Rev Pharmacol Toxicol; 1983; 23():29-44. PubMed ID: 6135389
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does antihypertensive treatment reduce the incidence of coronary disease?].
    Hansson L
    Cardiologia; 1984; 29(1-2):19-25. PubMed ID: 6152541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention of myocardial infarct using beta-blockers].
    Vacheron A
    Bull Acad Natl Med; 1985 Mar; 169(3):369-73. PubMed ID: 2864119
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of beta-blockers in the secondary prevention of acute myocardial infarcts. Status and recomendations].
    Jurgensen HJ
    Ugeskr Laeger; 1984 Mar; 146(12):863-8. PubMed ID: 6144204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction].
    Jensen G; Sigurd B
    Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta blocking agents: current status in the prevention of sudden coronary death.
    Hjalmarson A
    Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
    Borhani NO
    JAMA; 1985 Jul; 254(2):257-62. PubMed ID: 2860255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
    Löllgen H; Schmidt A; Upmeyer HJ
    Med Klin (Munich); 1986 Nov; 81(23):745-50. PubMed ID: 2880283
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-blockers and secondary prevention after myocardial infarction].
    Kher A; Jaillon P
    Therapie; 1984; 39(2):189-96. PubMed ID: 6145232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Kronmal RA
    JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta receptor blockers in acute myocardial infarct and in secondary prevention].
    Werdan K
    Internist (Berl); 1991 Jun; 32(6):359-60. PubMed ID: 1679049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.